Skip to content
Friday, December 1, 2023
Latest:
  • All about prosthesis
  • How neurotransmitters work together to detect odors
  • Turf vs. grass: field of dreams or field of injuries?
  • Baylor surgeon treats rare condition
  • Exploring the complexity of ethics and Artificial Intelligence: Reflections and responsibilities
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

pralsetinib

From The Labs

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

May 16, 2023May 16, 2023 endocrine therapy-resistant breast cancer,  ER+ breast cancer,  estrogen receptor 1,  fusion genes,  pralsetinib,  Research,  RET kinase

The findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.

Read More

From the Labs Image of the Month

Microscope image of the connections among crucial neurons within the visual pathway in the thalamus in the brain. From the Labs: Neural connections in the visual pathway of the brain

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951